WHO programme / 23 October 2019
Dili, Timor Leste. Photo: Tanushree Rao on Unsplash
Timor Leste becomes the latest associate member of WHO Programme for International Drug Monitoring.
In May 2019, Timor Leste joined the WHO Programme for International Drug Monitoring as an associate member. Timor Leste, which first gained independence and became a United Nations member state in 2002, is now one of 30 associate members alongside the 136 full members of the WHO programme.
Read more:
Uppsala Reports editor
@UMCGlobalSafety
WHO and UMC introduce new VigiBase access conditions, enhancing data sharing clarity and stakeholder confidence in global pharmacovigilance.
WHO programme / 20 March 2025
Since 2021 PAHO has assisted 12 countries in importing more than 270,000 historic and new cases to the global database.
WHO programme / 27 March 2025
Since its introduction 20 years ago, UMC’s adverse event reporting system has become the world’s most widely used safety surveillance toolkit for medicines and vaccines.
WHO programme / 25 November 2024
